๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study

โœ Scribed by S Bruno; E Silini; A Crosignani; F Borzio; G Leandro; F Bono; M Asti; S Rossi; A Larghi; A Cerino; M Podda; M U Mondelli


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
187 KB
Volume
25
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

โœฆ Synopsis


approximately 3%. 3,4 Early detection of HCC in cirrhotic pa-A prospective study was performed to establish tients can usually be achieved by screening with noninvasive whether infection with specific hepatitis C virus (HCV)

techniques, such as ultrasound (US) scan and serum a-fetogenotypes was associated with an increased risk of protein (AFP) concentration. 5,6 development of hepatocellular carcinoma (HCC) in cir-Over the years, several lines of experimental evidence indirhosis. A cohort of 163 consecutive hepatitis C virus anticated that male sex, age, and alcohol consumption 4,7,8 were body (anti-HCV)-positive cirrhotic patients was proclosely associated with the development of HCC in cirrhotic spectively evaluated for the development of HCC at patients. The identification of additional variables associated 6-month intervals by ultrasound (US) scan and awith an increased risk of developing HCC would be particufetoprotein (AFP) concentration. HCV genotypes were larly important to optimize preventive medical programs in determined according to Okamoto. Risk factors associthis setting. Recent studies suggested a possible role for HCV ated with cancer development were analyzed by univarigenotype in chronic liver disease outcome and, specifically, ate and multivariate statistics. At enrollment, 101 pa-

HCV type 1 was more frequently found in advanced liver tients (62%) were infected with type 1b, 48 (29.5%) were disease, such as cirrhosis and HCC, 9-11 and was associated infected with type 2a/c, 2 (1.2%) were infected with type with a more rapid deterioration of liver histology in chronic 3a, 1 (0.6%) was infected with type 1a, 3 (1.8%) had a hepatitis. 12 We have studied the distribution of HCV genomixed-type infection, and, in 8 patients (4.9%), genotype types in a cohort of patients with cirrhosis prospectively folcould not be assigned. After a 5-to 7-year follow-up (melowed for early detection of HCC, and we performed multivardian, 68 months), HCC developed in 22 of the patients, iate analysis to evaluate the independent risk for tumor 19 infected with type 1b and 3 with type 2a/c (P รต .005).

development associated with specific HCV types and with Moreover, HCC developed more frequently in males (P other variables, including interferon treatment, which has รต .01), patients with excessive alcohol intake (P รต .01), been recently reported to reduce the cancer risk in HCVthose over 60 years of age (P รต .02), and in patients who induced cirrhosis. 13 did not receive interferon treatment (P รต .02). Multivariate analysis showed that type 1b was the most important PATIENTS AND METHODS risk factor associated with tumor development (odds ra-


๐Ÿ“œ SIMILAR VOLUMES


Hepatitis C virus genotype 1b and risk o
โœ R Romeo; M G Rumi; N i Del; M Colombo ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 138 KB ๐Ÿ‘ 1 views

Hepatitis C Virus Genotype 1b and Risk of Hepatocellular Carcinoma and high baseline AFP were the only variables independently To the Editor: correlated with the risk of developing HCC. Thus, our prospective study, based on a larger number of We read with interest the article by Bruno et al. (p. 75

Increased risk of hepatocellular carcino
โœ Bart J. Veldt; Wendong Chen; E. Jenny Heathcote; Heiner Wedemeyer; Juerg Reichen ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 226 KB ๐Ÿ‘ 2 views

Recent studies suggest that diabetes mellitus increases the risk of developing hepatocellular carcinoma (HCC). The aim of this study is to quantify the risk of HCC among patients with both diabetes mellitus and hepatitis C in a large cohort of patients with chronic hepatitis C and advanced fibrosis.